BackgroundCirculating cell-free DNA (cfDNA) offers a promising noninvasive way to predict resistance to immune-checkpoint inhibitors (ICI), for which robust biomarkers are still lacking.MethodsThe SChISM (Size CfDNA Immunotherapy Signature Monitoring ...
Boutonnet, Audrey +11 more
core +3 more sources
DNAviWEB: sequencing-free clinical screening of liquid biopsies. [PDF]
Hess A, Matani Y, Seelow D, Kretzmer H.
europepmc +1 more source
Cell-free DNA fragmentomics: a universal framework for early cancer detection and monitoring. [PDF]
Dong W, Hu W, Lu Y, Zheng Q.
europepmc +1 more source
plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid Tumors. [PDF]
Canzoniero JV +24 more
europepmc +1 more source
Editorial: The emerging role of liquid biopsy in gastrointestinal, pancreatic and liver cancers. [PDF]
Iacob R, Paul D, Popescu I.
europepmc +1 more source
Sinteza nove piridinijeve soli s triazolilidenskim fragmentom
This thesis describes the synthesis of a novel pyridinium salt bearing triazolylidene fragment bounded to pyridine nitrogen atom, which has not yet been described in the literature. The synthesized salt represents a potential bidentate dicarbene NHC ligand, useful for the formation of transition metal NHC complexes.
openaire +1 more source
Cancer in a Drop: Liquid biopsy insights from AACR 2025. [PDF]
Maheswaran S +7 more
europepmc +1 more source
Liquid biopsies for early detection of gliomas: are we near a breakthrough? [PDF]
Amjad A, Ali MR, Khalid M, Segawa F.
europepmc +1 more source
Characterization of global cfDNA fragmentomics in Melanoma Patients
J.L. Villanueva-Cañas +8 more
openaire +1 more source
Integrating artificial intelligence with circulating tumor DNA for non-small cell lung cancer: opportunities, challenges, and future directions. [PDF]
Thalambedu N +6 more
europepmc +1 more source

